Skip to content
← Back to this collection

PUBLICATIONS · 23782935

Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2013 Aug 8
First author
Quintás-Cardama A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Quintás-Cardama A
      type
      Author
    2. name
      Abdel-Wahab O
      type
      Author
    3. name
      Manshouri T
      type
      Author
    4. name
      Kilpivaara O
      type
      Author
    5. name
      Cortes J
      type
      Author
    6. name
      Roupie AL
      type
      Author
    7. name
      Zhang SJ
      type
      Author
    8. name
      Harris D
      type
      Author
    9. name
      Estrov Z
      type
      Author
    10. name
      Kantarjian H
      type
      Author
    11. name
      Levine RL
      type
      Author
    12. name
      Verstovsek S
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Quintás-Cardama A
      type
      Author
    2. name
      Abdel-Wahab O
      type
      Author
    3. name
      Manshouri T
      type
      Author
    4. name
      Kilpivaara O
      type
      Author
    5. name
      Cortes J
      type
      Author
    6. name
      Roupie AL
      type
      Author
    7. name
      Zhang SJ
      type
      Author
    8. name
      Harris D
      type
      Author
    9. name
      Estrov Z
      type
      Author
    10. name
      Kantarjian H
      type
      Author
    11. name
      Levine RL
      type
      Author
    12. name
      Verstovsek S
      type
      Author
    bibliography ids
    1. nci-bib-d6b691eacf0d7ececd9b1b99
    book metadata
    content sha256
    294151fb654c7529e9fcab539937a4bacf82d3c211391886bf0e7085bf209dcf
    document type
    citation
    dois
    1. 10.1182/blood-2012-07-442012
    electronic publication date
    display
    2013 Jun 19
    precision
    day
    year
    2013
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:23782935
    immutable id
    pubmed:23782935@294151fb654c7529e9fcab539937a4bacf82d3c211391886bf0e7085bf209dcf
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    6
    name
    Blood
    nlm unique id
    7603509
    pages
    893-901
    volume
    122
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      23782935
      provenance
      batch id
      0a08f044391426feb8ef
      provider
      NCBI PubMed ESummary
      record sha256
      4245008d8c526a0fc15c7f911cf4d26ed0945812cfcb40bc43f527eab8b1c4f3
      response sha256
      d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
      retrieved at
      2026-09-09T23:46:57.614689+00:00
      publication date
      display
      2013 Aug 8
      precision
      day
      year
      2013
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, N.I.H., Extramural
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/23782935/
      title
      Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a.

      Preserved source evidence · Not medical advice